Rajendra Prakash Maurya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rajendra Prakash Maurya has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
Sneha Gupta
Regional Institute of Ophthalmology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
8 shared publications- Syeed Mehbub Ul Kadir
Department of Oculoplasty, National Institute of Ophthalmology and Hospital, Dhaka, Bangladesh
6 shared publications Virendra Pratap Singh
Regional Institute of Ophthalmology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
6 shared publicationsKokil Tiwari
Institute of Medical Sciences, Varanasi, Uttar Pradesh, India
5 shared publicationsMeghna Roy
4 shared publicationsAalok Kumar
Regional Institute of Ophthalmology, Institute of Medical Sciences, Varanasi, Uttar Pradesh, India
3 shared publications
Latest Publications
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Oman Journal of Ophthalmology
- Vol. 18  (3) , 308-314
Serum vascular endothelial growth factor in patients with nonmelanoma primary ocular malignancies: A possible potential biomarker of tumor progression and poor prognosis
CONTEXT: Vascular endothelial growth factor (VEGF) is a potent and specific angiogenic growth factor that may participate in the formation of the vascular tumor stroma. Pretreatment VEGF levels can be a biomarker to predict tumor progression and prognosis in patients with primary ocular malignancies. AIMS: The aim of this study was to estimate the serum vascular endothelial growth factor (VEGF) in various ocular malignancies, correlate with clinicpathological parameters, and assess its prognostic and therapeutic implications. SETTINGS AND DESIGN: This hospital-based observational study includes a total of 32 newly diagnosed histopathologically confirmed, patients with ocular malignancy. SUBJECTS AND METHODS: Circulating VEGF levels were measured using as and which enzyme-linked immunosorbent assay technique in 32 patients and 16 healthy controls. Serum VEGF levels were expressed as means ± standard deviation and compared using a one-way analysis of variance test, Chi-squared test, and Student’s t -test were used. RESULTS: Mean serum VEGF levels were significantly raised in patients as compared to healthy controls (79.85 ± 22.16 vs 67.15 ± 6.84 pg/ml). Moreover, VEGF levels were maximum in retinoblastoma (111.86 ± 33.54 pg/ml), followed by sebaceous gland carcinoma (77.83 ± 11.37 pg/ml), ocular surface squamous neoplasia (70.57 ± 5.84 pg/ml), and basal cell carcinoma (67.96 ± 4.55 pg/ml). No significant change in serum VEGF level depending on histopathological differentiation ( P = 0.151). Overall, VEGF levels were markedly elevated in the advanced stage as compared to those with the early stage (94.43 ± 26.71 vs. 68.51 ± 6.20 pg/ml). Significant increase in VEGF levels was also found in patients with lymph node metastasis (108.90 ± 27.31 pg/ml, P < 0.001) and distant metastasis (124.71 ± 28.27 pg/ml, P < 0.001). In addition, recurrence was observed in 18.75% of patients with high-level VEGF (104.69 ± 35.78 pg/ml). CONCLUSIONS: Serum VEGF may be a useful biomarker to assess disease severity, predict prognosis, and assess the likelihood of recurrence in various ocular cancers.
- 1 September 2025
- Published by Wolters Kluwer Health in Oman Journal of Ophthalmology
- Vol. 18  (3) , 308-314
Open AccessSerum vascular endothelial growth factor in patients with nonmelanoma primary ocular malignancies: A possible potential biomarker of tumor progression and poor prognosis
CONTEXT: Vascular endothelial growth factor (VEGF) is a potent and specific angiogenic growth factor that may participate in the formation of the vascular tumor stroma. Pretreatment VEGF levels can be a biomarker to predict tumor progression and prognosis in patients with primary ocular malignancies. AIMS: The aim of this study was to estimate the serum vascular endothelial growth factor (VEGF) in various ocular malignancies, correlate with clinicpathological parameters, and assess its prognostic and therapeutic implications. SETTINGS AND DESIGN: This hospital-based observational study includes a total of 32 newly diagnosed histopathologically confirmed, patients with ocular malignancy. SUBJECTS AND METHODS: Circulating VEGF levels were measured using as and which enzyme-linked immunosorbent assay technique in 32 patients and 16 healthy controls. Serum VEGF levels were expressed as means ± standard deviation and compared using a one-way analysis of variance test, Chi-squared test, and Student’s t -test were used. RESULTS: Mean serum VEGF levels were significantly raised in patients as compared to healthy controls (79.85 ± 22.16 vs 67.15 ± 6.84 pg/ml). Moreover, VEGF levels were maximum in retinoblastoma (111.86 ± 33.54 pg/ml), followed by sebaceous gland carcinoma (77.83 ± 11.37 pg/ml), ocular surface squamous neoplasia (70.57 ± 5.84 pg/ml), and basal cell carcinoma (67.96 ± 4.55 pg/ml). No significant change in serum VEGF level depending on histopathological differentiation ( P = 0.151). Overall, VEGF levels were markedly elevated in the advanced stage as compared to those with the early stage (94.43 ± 26.71 vs. 68.51 ± 6.20 pg/ml). Significant increase in VEGF levels was also found in patients with lymph node metastasis (108.90 ± 27.31 pg/ml, P < 0.001) and distant metastasis (124.71 ± 28.27 pg/ml, P < 0.001). In addition, recurrence was observed in 18.75% of patients with high-level VEGF (104.69 ± 35.78 pg/ml). CONCLUSIONS: Serum VEGF may be a useful biomarker to assess disease severity, predict prognosis, and assess the likelihood of recurrence in various ocular cancers.
- Open Access
- 15 December 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (4) , 639-644
Central macular thickness after uneventful phacoemulsification and MSICS: A prospective comparison
The aim of this study was to evaluate and compare central macular thickness using spectral domain OCT in patients undergoing small incision cataract surgery and phacoemulsification. This prospective, comparative and observational study was conducted on 120 cataract patients. They were equally divided into Group 1 and Group 2. Group 1 patients who underwent phacoemulsification and Group 2 who underwent MSICS. In both groups macular thickness using OCT was recorded preoperatively and postoperatively at 1 day, 1, 4, 6 weeks. Macular thickness changes were analyzed and compared. : There was an increase in central macular thickness Post cataract surgery which was more (240.07 ± 21.28) in patients who underwent small incision cataract surgery up to 6 weeks as compared to the patients who underwent phacoemulsification was (220.73 ± 12.75) with p value < 0.05. However, there was no significant association with the age, gender and preoperative central macular thickness. Increase in macular thickness remained subclinical and there was no significant association with the age, gender and pre-operative central macular thickness.
- 15 December 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (4) , 639-644
Open AccessCentral macular thickness after uneventful phacoemulsification and MSICS: A prospective comparison
The aim of this study was to evaluate and compare central macular thickness using spectral domain OCT in patients undergoing small incision cataract surgery and phacoemulsification. This prospective, comparative and observational study was conducted on 120 cataract patients. They were equally divided into Group 1 and Group 2. Group 1 patients who underwent phacoemulsification and Group 2 who underwent MSICS. In both groups macular thickness using OCT was recorded preoperatively and postoperatively at 1 day, 1, 4, 6 weeks. Macular thickness changes were analyzed and compared. : There was an increase in central macular thickness Post cataract surgery which was more (240.07 ± 21.28) in patients who underwent small incision cataract surgery up to 6 weeks as compared to the patients who underwent phacoemulsification was (220.73 ± 12.75) with p value < 0.05. However, there was no significant association with the age, gender and preoperative central macular thickness. Increase in macular thickness remained subclinical and there was no significant association with the age, gender and pre-operative central macular thickness.
- Open Access
- 15 December 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (4) , 660-666
Comparative analysis of central corneal thickness and macular thickness changes following phacoemulsification and small incision cataract surgery: A prospective study
To quantify the changes in central corneal thickness and macular thickness after uncomplicated cataract surgery and to compare its outcomes in terms of visual acuity. : A total of 81 patients with senile cataract who were scheduled for either Phacoemulsification or SICS surgery were included in this study. They were divided into two groups: 41 patients underwent Phacoemulsification and 40 patients underwent SICS. CCT and CMT were measured with optical coherence tomography (OCT) preoperatively and postoperatively at Day 1, day 7, week 6 and 3 months.: Preoperative baseline measurements showed no significant difference in CCT and MT between the two groups (p > 0.05). Central corneal thickness showed significant differences between the two groups at different postoperative time points at day 1 and day 7. Central macular thickness also showed significant differences at day 7 and 6 week, with the SICS group showing consistently higher macular thickness values compared to the Phacoemulsification group from day 1 to 3 months after surgery. This suggested that the type of cataract surgery may have had an impact on retinal thickness outcomes, with more pronounced and permanent changes occurring in the SICS group. In addition, both group A (SICS) and group B (Phacoemulsification) showed good visual outcomes, with comparable improvements in BCVA.: Our results suggested that both SICS and Phacoemulsification techniques are effective in improving visual acuity, but SICS may result in more pronounced retinal changes while faster resolution of macular thickness was seen in phacoemulsification. Both groups also exhibited transient subclinical changes in CCT following cataract surgery. However, these changes were generally reversible, and early recovery occurred after phacoemulsification. The visual acuity was improved after both procedures but phacoemulsification surgery showed slightly better visual outcomes. Understanding these differences may help to adjust postoperative treatment strategies to optimize outcomes for patients undergoing cataract surgery.
- 15 December 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (4) , 660-666
Open AccessComparative analysis of central corneal thickness and macular thickness changes following phacoemulsification and small incision cataract surgery: A prospective study
To quantify the changes in central corneal thickness and macular thickness after uncomplicated cataract surgery and to compare its outcomes in terms of visual acuity. : A total of 81 patients with senile cataract who were scheduled for either Phacoemulsification or SICS surgery were included in this study. They were divided into two groups: 41 patients underwent Phacoemulsification and 40 patients underwent SICS. CCT and CMT were measured with optical coherence tomography (OCT) preoperatively and postoperatively at Day 1, day 7, week 6 and 3 months.: Preoperative baseline measurements showed no significant difference in CCT and MT between the two groups (p > 0.05). Central corneal thickness showed significant differences between the two groups at different postoperative time points at day 1 and day 7. Central macular thickness also showed significant differences at day 7 and 6 week, with the SICS group showing consistently higher macular thickness values compared to the Phacoemulsification group from day 1 to 3 months after surgery. This suggested that the type of cataract surgery may have had an impact on retinal thickness outcomes, with more pronounced and permanent changes occurring in the SICS group. In addition, both group A (SICS) and group B (Phacoemulsification) showed good visual outcomes, with comparable improvements in BCVA.: Our results suggested that both SICS and Phacoemulsification techniques are effective in improving visual acuity, but SICS may result in more pronounced retinal changes while faster resolution of macular thickness was seen in phacoemulsification. Both groups also exhibited transient subclinical changes in CCT following cataract surgery. However, these changes were generally reversible, and early recovery occurred after phacoemulsification. The visual acuity was improved after both procedures but phacoemulsification surgery showed slightly better visual outcomes. Understanding these differences may help to adjust postoperative treatment strategies to optimize outcomes for patients undergoing cataract surgery.
- Open Access
- 15 December 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (4) , 623-626
Importance of ocular trauma score (OTS) system
Importance of ocular trauma score (OTS) system - IJCEO- Print ISSN No: - 2395-1443 Online ISSN No:- 2395-1451 Article DOI No:- 10.18231/j.ijceo.2024.109, Indian Journal of Clinical and Experimental Ophthalmology-Indian J Clin Exp Ophthalmol
- 15 December 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (4) , 623-626
Open AccessImportance of ocular trauma score (OTS) system
Importance of ocular trauma score (OTS) system - IJCEO- Print ISSN No: - 2395-1443 Online ISSN No:- 2395-1451 Article DOI No:- 10.18231/j.ijceo.2024.109, Indian Journal of Clinical and Experimental Ophthalmology-Indian J Clin Exp Ophthalmol
- Open Access
- 15 November 2024
- Published by IP Innovative Publication Pvt Ltd in IP International Journal of Ocular Oncology and Oculoplasty
- Vol. 10  (3) , 114-116
Recent advances in the management of uveal melanoma
Recent advances in the management of uveal melanoma - IJOOO- Print ISSN No: - 2581-5024 Online ISSN No:- 2581-5016 Article DOI No:- 10.18231/j.ijooo.2024.023, IP International Journal of Ocular Oncology and Oculoplasty-IP Int J Ocul Oncol Oculoplasty
- 15 November 2024
- Published by IP Innovative Publication Pvt Ltd in IP International Journal of Ocular Oncology and Oculoplasty
- Vol. 10  (3) , 114-116
Open AccessRecent advances in the management of uveal melanoma
Recent advances in the management of uveal melanoma - IJOOO- Print ISSN No: - 2581-5024 Online ISSN No:- 2581-5016 Article DOI No:- 10.18231/j.ijooo.2024.023, IP International Journal of Ocular Oncology and Oculoplasty-IP Int J Ocul Oncol Oculoplasty
- Open Access
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (3) , 454-458
To study efficacy of tacrolimus (0.03%) Eye ointment, cyclosporine (0.1%) eye drops and fluorometholone (0.1%) eye drops in vernal keratoconjunctivitis
VKC (Vernal keratoconjunctivitis) is a chronic, bilateral ocular inflammatory disorder that primarily impacts young patients. Management of VKC is challenging due to its complex immunological etiology and chronic inflammatory components. This prospective, single-center, randomized study was executed at the Outpatient Department of Ophthalmology, SGT Medical College, Hospital and Research Institute (FMHS), Budhera, Gurugram, for a duration of 18 months. A total of 102 clinically diagnosed VKC patients, aged above 5 years, have been then randomly divided into 3 groups (34 each). Group A received fluorometholone (0.1%) eye drops, Group B received cyclosporine (0.1%) eye drops, and Group C received tacrolimus (0.03%) eye ointment. Patients were evaluated at days 0, 7, 14, 28, 35, and two weeks post-medication using the Clinical Scoring System by Bleik and Tabbara to assess TSSS (Total Subjective Symptom Score) and TOSS (Total Objective Ocular Sign Score). Most patients were between 6-10 years old, with over 78% being males. Group A showed significant symptom reduction from the first week (mean TSSS reduction from 2.29±0.46 to 0.21±0.41, p<0.0001), while Groups B and C showed significant improvements from the second week (Group B: mean TSSS reduction from 2.5±0.51 to 0.12±0.33, p<0.0001; Group C: mean TSSS reduction from 2.29±0.46 to 1.00±0.00, p<0.0001). Conjunctival hyperemia and tarsal papillae improvements were more pronounced in Group B as compared to Groups A & C. No ocular complications were found, except for dose-dependent irritation in Group C. While fluorometholone (0.1percent) eye drops provided early symptom relief, its effects were not sustained. Cyclosporine (0.1percent) eye drops and tacrolimus (0.03percent) eye ointment showed delayed but sustained efficacy, making them suitable for long-term treatment of moderate to severe VKC. Fluorometholone may be used initially alongside immunomodulators for rapid symptom relief, followed by tapering as immunomodulators take effect.
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (3) , 454-458
Open AccessTo study efficacy of tacrolimus (0.03%) Eye ointment, cyclosporine (0.1%) eye drops and fluorometholone (0.1%) eye drops in vernal keratoconjunctivitis
VKC (Vernal keratoconjunctivitis) is a chronic, bilateral ocular inflammatory disorder that primarily impacts young patients. Management of VKC is challenging due to its complex immunological etiology and chronic inflammatory components. This prospective, single-center, randomized study was executed at the Outpatient Department of Ophthalmology, SGT Medical College, Hospital and Research Institute (FMHS), Budhera, Gurugram, for a duration of 18 months. A total of 102 clinically diagnosed VKC patients, aged above 5 years, have been then randomly divided into 3 groups (34 each). Group A received fluorometholone (0.1%) eye drops, Group B received cyclosporine (0.1%) eye drops, and Group C received tacrolimus (0.03%) eye ointment. Patients were evaluated at days 0, 7, 14, 28, 35, and two weeks post-medication using the Clinical Scoring System by Bleik and Tabbara to assess TSSS (Total Subjective Symptom Score) and TOSS (Total Objective Ocular Sign Score). Most patients were between 6-10 years old, with over 78% being males. Group A showed significant symptom reduction from the first week (mean TSSS reduction from 2.29±0.46 to 0.21±0.41, p<0.0001), while Groups B and C showed significant improvements from the second week (Group B: mean TSSS reduction from 2.5±0.51 to 0.12±0.33, p<0.0001; Group C: mean TSSS reduction from 2.29±0.46 to 1.00±0.00, p<0.0001). Conjunctival hyperemia and tarsal papillae improvements were more pronounced in Group B as compared to Groups A & C. No ocular complications were found, except for dose-dependent irritation in Group C. While fluorometholone (0.1percent) eye drops provided early symptom relief, its effects were not sustained. Cyclosporine (0.1percent) eye drops and tacrolimus (0.03percent) eye ointment showed delayed but sustained efficacy, making them suitable for long-term treatment of moderate to severe VKC. Fluorometholone may be used initially alongside immunomodulators for rapid symptom relief, followed by tapering as immunomodulators take effect.
- Open Access
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (3) , 464-469
Comparison of corneal ulcer size and depth measurement by slit lamp and anterior segment optical coherence tomography
To evaluate the correlation between corneal ulcer size and depth measurements using slit lamp biomicroscopy and anterior segment optical coherence tomography (AS-OCT). A prospective, observational study was conducted on 100 patients with corneal ulcers at the Hind Institute of Medical Sciences after taking clearance from the ethical committee. Corneal ulcer parameters, including width, height, and depth, were measured and compared using both slit lamp biomicroscopy and AS-OCT.The mean age of patients was 45.74±13.61 years ranging from 22 to 78 years. Majority of patients were males (75%). Right eye was involved among more than half of patients (65%) followed by left eye (35%). The length and depth of infiltrate was significantly (p=0.001) lower by SLIT LAMP than ASOCT method observed by both the observers. The breadth of infiltrate was significantly (p<0.05) higher by SLIT LAMP than ASOCT method observed by both the observers. Corneal thickness measured by ASOCT was significantly (p=0.04) lower evaluated by observer 1 (637.76±135.26) than observer 2 (640.66±130.16). Highly significant positive (p=0.0001) correlation was found between SLIT and ASOCT in all the measurements evaluated by both the observers.AS-OCT provides accurate and non-invasive measurements of corneal ulcer depth, which is not possible with slit lamp biomicroscopy. The use of AS-OCT as an adjunctive modality can enhance diagnosis and management of corneal ulcers. This study highlights the utility of AS-OCT in monitoring disease activity and providing valuable imaging guidelines for clinicians.
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (3) , 464-469
Open AccessComparison of corneal ulcer size and depth measurement by slit lamp and anterior segment optical coherence tomography
To evaluate the correlation between corneal ulcer size and depth measurements using slit lamp biomicroscopy and anterior segment optical coherence tomography (AS-OCT). A prospective, observational study was conducted on 100 patients with corneal ulcers at the Hind Institute of Medical Sciences after taking clearance from the ethical committee. Corneal ulcer parameters, including width, height, and depth, were measured and compared using both slit lamp biomicroscopy and AS-OCT.The mean age of patients was 45.74±13.61 years ranging from 22 to 78 years. Majority of patients were males (75%). Right eye was involved among more than half of patients (65%) followed by left eye (35%). The length and depth of infiltrate was significantly (p=0.001) lower by SLIT LAMP than ASOCT method observed by both the observers. The breadth of infiltrate was significantly (p<0.05) higher by SLIT LAMP than ASOCT method observed by both the observers. Corneal thickness measured by ASOCT was significantly (p=0.04) lower evaluated by observer 1 (637.76±135.26) than observer 2 (640.66±130.16). Highly significant positive (p=0.0001) correlation was found between SLIT and ASOCT in all the measurements evaluated by both the observers.AS-OCT provides accurate and non-invasive measurements of corneal ulcer depth, which is not possible with slit lamp biomicroscopy. The use of AS-OCT as an adjunctive modality can enhance diagnosis and management of corneal ulcers. This study highlights the utility of AS-OCT in monitoring disease activity and providing valuable imaging guidelines for clinicians.
- Open Access
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (3) , 395-398
Gene therapy for glaucoma: A paradigm shift in treatment
Gene therapy for glaucoma: A paradigm shift in treatment - IJCEO- Print ISSN No: - 2395-1443 Online ISSN No:- 2395-1451 Article DOI No:- 10.18231/j.ijceo.2024.070, Indian Journal of Clinical and Experimental Ophthalmology-Indian J Clin Exp Ophthalmol
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (3) , 395-398
Open AccessGene therapy for glaucoma: A paradigm shift in treatment
Gene therapy for glaucoma: A paradigm shift in treatment - IJCEO- Print ISSN No: - 2395-1443 Online ISSN No:- 2395-1451 Article DOI No:- 10.18231/j.ijceo.2024.070, Indian Journal of Clinical and Experimental Ophthalmology-Indian J Clin Exp Ophthalmol
- Open Access
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (3) , 441-446
Efficacy of topical autologous serum versus preservative free artificial tears in patients having isotretinoin induced dry eye diseases
Aim of this study was to compare the efficacy and safety of topical autologous serum versus preservative free artificial tears in management of systemic Isotretinoin induced dry eye In this prospective observational analytical study a total of 182 eyes of 97 patients with systemic Isotretinoin induced dry eye were enrolled. Baseline evaluations including the ocular surface disease index (OSDI) scoring, Schirmer’s test, tear film break up time (TBUT) and National Eye Institute (NEI) grading for corneal and conjunctival staining were performrd. All study subject were underwent thorough ophthalmic examinations including best-corrected visual acuity (BCVA) assessments and intraocular pressure measurements. The study participants were divided into two groups: group I treated with 40% autologous serum (AS) and group II treated with preservative free artificial tears (PFAT). Follow-up evaluation were conducted at 15 days, 1 month, 2 months, and 3 months. Statistical Analysis: The results were analyzed using the Chi-square test and t-test. P<0.05 was considered statistically significant.: After 3 months of treatment, a significant improvement was noticed in OSDI, Schirmer’s test, TBUT, and NEI Scoring in both AS and PFAT groups but improvement was found stronger in AS group as compared to PFAT group (p < 0.001).Topical autologous serum may be an effective alternative for treatment of dry eye condition caused by drug Isotretinoin.
- 15 September 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 10  (3) , 441-446
Open AccessEfficacy of topical autologous serum versus preservative free artificial tears in patients having isotretinoin induced dry eye diseases
Aim of this study was to compare the efficacy and safety of topical autologous serum versus preservative free artificial tears in management of systemic Isotretinoin induced dry eye In this prospective observational analytical study a total of 182 eyes of 97 patients with systemic Isotretinoin induced dry eye were enrolled. Baseline evaluations including the ocular surface disease index (OSDI) scoring, Schirmer’s test, tear film break up time (TBUT) and National Eye Institute (NEI) grading for corneal and conjunctival staining were performrd. All study subject were underwent thorough ophthalmic examinations including best-corrected visual acuity (BCVA) assessments and intraocular pressure measurements. The study participants were divided into two groups: group I treated with 40% autologous serum (AS) and group II treated with preservative free artificial tears (PFAT). Follow-up evaluation were conducted at 15 days, 1 month, 2 months, and 3 months. Statistical Analysis: The results were analyzed using the Chi-square test and t-test. P<0.05 was considered statistically significant.: After 3 months of treatment, a significant improvement was noticed in OSDI, Schirmer’s test, TBUT, and NEI Scoring in both AS and PFAT groups but improvement was found stronger in AS group as compared to PFAT group (p < 0.001).Topical autologous serum may be an effective alternative for treatment of dry eye condition caused by drug Isotretinoin.
- Open Access
- 15 August 2024
- Published by IP Innovative Publication Pvt Ltd in IP International Journal of Ocular Oncology and Oculoplasty
- Vol. 10  (2) , 63-66
Orbital biopsy
Orbital biopsy - IJOOO- Print ISSN No: - 2581-5024 Online ISSN No:- 2581-5016 Article DOI No:- 10.18231/j.ijooo.2024.013, IP International Journal of Ocular Oncology and Oculoplasty-IP Int J Ocul Oncol Oculoplasty
- 15 August 2024
- Published by IP Innovative Publication Pvt Ltd in IP International Journal of Ocular Oncology and Oculoplasty
- Vol. 10  (2) , 63-66
Open AccessOrbital biopsy
Orbital biopsy - IJOOO- Print ISSN No: - 2581-5024 Online ISSN No:- 2581-5016 Article DOI No:- 10.18231/j.ijooo.2024.013, IP International Journal of Ocular Oncology and Oculoplasty-IP Int J Ocul Oncol Oculoplasty